K. Kretzmer

发表

2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitor.

R. Compton, Wei Huang, A. Thorarensen, 2009, Bioorganic & medicinal chemistry letters.

IKK-i and TBK-1 are Enzymatically Distinct from the Homologous Enzyme IKK-2

D. Creely, S. Mathialagan, Q. K. Huynh, 2002, The Journal of Biological Chemistry.

Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit.

T. Wun, G. Broze, K. Day, 1990, Blood.

Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

J. Miletich, T. Girard, T. Wun, 1988, The Journal of biological chemistry.

cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell

T. Wun, K. Kretzmer, 1987, FEBS letters.

Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.

P. Tipping, J. Erlich, S. Holdsworth, 1996, The Journal of clinical investigation.

Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.

T. Wun, G. Broze, K. Fok, 1990, The Journal of biological chemistry.

Comparison of Recombinant Tissue Factor Pathway Inhibitors Expressed in Human SK Hepatoma, Mouse C127, Baby Hamster Kidney, and Chinese Hamster Ovary Cells

W. Novotny, R. Leimgruber, G. Broze, 1992, Thrombosis and Haemostasis.

Refold and Characterization of Recombinant Tissue Factor Pathway Inhibitor Expressed in Escherichia coli

K. Duffin, R. Frazier, T. Wun, 1994, Thrombosis and Haemostasis.